Veru Inc.

NasdaqCM:VERU 株式レポート

時価総額：US$110.4m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Veru マネジメント

マネジメント 基準チェック /34

現在、CEO に関する十分な情報がありません。

主要情報

Mitch Steiner

最高経営責任者

US$4.7m

報酬総額

CEO給与比率18.4%
CEO在任期間8yrs
CEOの所有権4.8%
経営陣の平均在職期間6.1yrs
取締役会の平均在任期間3.8yrs

経営陣の近況

Recent updates

Is Veru (NASDAQ:VERU) A Risky Investment?

Aug 07
Is Veru (NASDAQ:VERU) A Risky Investment?

What Veru Inc.'s (NASDAQ:VERU) 28% Share Price Gain Is Not Telling You

Jul 17
What Veru Inc.'s (NASDAQ:VERU) 28% Share Price Gain Is Not Telling You

Veru Inc.'s (NASDAQ:VERU) 35% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

May 31
Veru Inc.'s (NASDAQ:VERU) 35% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

The Price Is Right For Veru Inc. (NASDAQ:VERU) Even After Diving 52%

Jan 09
The Price Is Right For Veru Inc. (NASDAQ:VERU) Even After Diving 52%

Revenue Downgrade: Here's What Analysts Forecast For Veru Inc. (NASDAQ:VERU)

Aug 16
Revenue Downgrade: Here's What Analysts Forecast For Veru Inc. (NASDAQ:VERU)

Veru Inc.'s (NASDAQ:VERU) Stock Retreats 38% But Revenues Haven't Escaped The Attention Of Investors

Apr 17
Veru Inc.'s (NASDAQ:VERU) Stock Retreats 38% But Revenues Haven't Escaped The Attention Of Investors

Veru Inc.'s (NASDAQ:VERU) Intrinsic Value Is Potentially 99% Above Its Share Price

Feb 14
Veru Inc.'s (NASDAQ:VERU) Intrinsic Value Is Potentially 99% Above Its Share Price

Veru (NASDAQ:VERU) Has Debt But No Earnings; Should You Worry?

Jan 13
Veru (NASDAQ:VERU) Has Debt But No Earnings; Should You Worry?

Analysts Just Shaved Their Veru Inc. (NASDAQ:VERU) Forecasts Dramatically

Nov 13
Analysts Just Shaved Their Veru Inc. (NASDAQ:VERU) Forecasts Dramatically

Veru Inc.: Safer Bet Is To Wait For The AdComm Verdict

Oct 17

Is Veru (NASDAQ:VERU) Weighed On By Its Debt Load?

Sep 26
Is Veru (NASDAQ:VERU) Weighed On By Its Debt Load?

Veru FDA AdCom meeting for COVID-19 therapy postponed

Sep 19

Veru: A Good Combination Of A Stable Business And Growth Opportunities

Sep 13

Veru surges 11% as FDA sets AdCom meeting to review COVID-19 therapy

Sep 07

Veru sheds 13% to end rally as director sells shares

Aug 18

Veru Q3 2022 Earnings Preview

Aug 10

Veru updated analysis on COVID treatment sabizabulin will lead to EUA - Oppenheimer

Aug 03

Veru eligible for expedited review in U.K. for COVID-19 therapy

Jul 25

Veru: The Signs Seem To Point To An EUA For Sabizabulin

Jul 13

CEO報酬分析

Veru の収益と比較して、Mitch Steiner の報酬はどのように変化したか？
日付総報酬給与会社業績
Jun 30 2024n/an/a

-US$37m

Mar 31 2024n/an/a

-US$39m

Dec 31 2023n/an/a

-US$63m

Sep 30 2023US$5mUS$866k

-US$93m

Jun 30 2023n/an/a

-US$126m

Mar 31 2023n/an/a

-US$136m

Dec 31 2022n/an/a

-US$116m

Sep 30 2022US$6mUS$761k

-US$84m

Jun 30 2022n/an/a

-US$47m

Mar 31 2022n/an/a

-US$28m

Dec 31 2021n/an/a

-US$16m

Sep 30 2021US$2mUS$618k

US$7m

Jun 30 2021n/an/a

-US$144k

Mar 31 2021n/an/a

-US$476k

Dec 31 2020n/an/a

US$2m

Sep 30 2020US$1mUS$502k

-US$19m

Jun 30 2020n/an/a

-US$10m

Mar 31 2020n/an/a

-US$10m

Dec 31 2019n/an/a

-US$13m

Sep 30 2019US$800kUS$392k

-US$12m

Jun 30 2019n/an/a

-US$17m

Mar 31 2019n/an/a

-US$22m

Dec 31 2018n/an/a

-US$22m

Sep 30 2018US$740kUS$383k

-US$24m

報酬と市場: Mitchの 総報酬 ($USD 4.71M ) は、 US市場 ($USD 673.68K ) の同規模の企業の平均を上回っています。

報酬と収益: Mitchの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Mitch Steiner (63 yo)

8yrs

在職期間

US$4,714,041

報酬

Dr. Mitchell S. Steiner, also known as Mitch, M.D., F.A.C.S, has been the Chief Executive Officer, President and Director at Veru Inc. (formerly known as The Female Health Company) since October 31, 2016 &...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Mitchell Steiner
Chairman8yrsUS$4.71m4.84%
$ 5.3m
Harry Fisch
Vice Chairman & Chief Corporate Officer8yrsデータなし5.47%
$ 6.0m
Michele Greco
CFO & Chief Administrative Officer6.8yrsUS$1.55m0.066%
$ 72.5k
K. Barnette
Chief Scientific Officer6.1yrsUS$1.69m0.0034%
$ 3.8k
Samuel Fisch
Executive Director of Investor Relations & Corporate Communications5.5yrsデータなしデータなし
Michael Purvis
Executive VP3.6yrsデータなしデータなし
Kevin Gilbert
Executive Vice President of Corporate Development7.8yrsデータなしデータなし
Martin Tayler
Executive Vice President of FC2 Global Operationsno dataUS$193.01kデータなし
Philip Greenberg
Executive VP & Deputy General Counsel3.8yrsデータなしデータなし
Domingo Rodriguez
Executive Vice President of Global Clinical Operations6.5yrsデータなしデータなし
Gary Bird
Executive Vice President of Quality & Regulatory Affairs5.7yrsデータなしデータなし
Jason Davies
Executive VP and GM of UK2.2yrsデータなしデータなし

6.1yrs

平均在職期間

62.5yo

平均年齢

経験豊富な経営陣: VERUの経営陣は経験豊富で経験豊富です（平均在職期間は5.8年）。

取締役

名称ポジション在職期間報酬所有権
Mitchell Steiner
Chairman8yrsUS$4.71m4.84%
$ 5.3m
Harry Fisch
Vice Chairman & Chief Corporate Officer8yrsデータなし5.47%
$ 6.0m
Louis Aronne
Chief Medical Advisor & Member of the Scientific Advisoryless than a yearデータなしデータなし
David D. Ho
Chairman of Scientific Advisory Board1.8yrsデータなしデータなし
Andrew Love
Board Observer8yrsデータなしデータなし
Robert Schooley
Member of the Scientific Advisory Board1.3yrsデータなしデータなし
Michael Rankowitz
Independent Director6.6yrsUS$875.93k0.068%
$ 75.4k
Xiaoqin Lu
Independent Director3.4yrsUS$835.75k0.0067%
$ 7.4k
Caroline Apovian
Member of Scientific Advisory Boardless than a yearデータなしデータなし
Mario Eisenberger
Independent Director8yrsUS$795.57k0%
$ 0
Grace Hyun
Independent Director4.2yrsUS$755.39k0.010%
$ 11.1k
Erik Swenson
Member of the Scientific Advisory Board1.3yrsデータなしデータなし

3.8yrs

平均在職期間

66yo

平均年齢

経験豊富なボード: VERUの 取締役会 は 経験豊富 であると考えられます ( 3.5年の平均在任期間)。